Malaria RTS,S Vaccine from Japan
Malaria RTS,S vaccine, a recombinant circumsporozoite protein-based vaccine formulated with the AS01 adjuvant system, is designed to protect against Plasmodium falciparum malaria. It is a biotechnologically obtained immunological product derived from protozoal cultures, falling under tariff item 3002.49.00 as 'Other' vaccines, toxins, or cultures of micro-organisms.
Duty Rate — Japan → Canada
Import Tips
• Ensure the vaccine is accompanied by a valid Canadian Drug Establishment Licence or import permit from Health Canada, as biologicals require pre-import authorization
• Declare the product under tariff item 3002.49.00 and be prepared to provide documentation proving its biotechnological origin to support classification
• Verify whether the shipment qualifies for duty-free treatment under Canada's Most-Favoured-Nation (MFN) tariff, but confirm current rates with the CBSA before shipping